Diabetes patients may soon begin to enjoy some succor, as Germany-based pharmaceutical company Boehringer Ingelheim has teamed up with blockchain healthcare platform Solve.Care.
The partnership would see the two of them providing assistance to people suffering from diabetes, through a blockchain network for data sharing.
The platform, dubbed the Diabetes Care Administration Network, will be based on Solve.Care’s existing blockchain platform and will contain patients information.
According to the statement released by Solve.care, this will make coordinating care for patients easier and also provide information regarding diabetes-associated risks as well as prevention and symptom.
Chief Executive Officer of Solve.care, Pradeep Goel, while speaking on the feat, said: “The Diabetes Care Administration Network will help bridge a knowledge gap by providing a platform which offers vital information on diabetes and cardiovascular diseases in an easily accessible manner.”
“This is invaluable in the healthcare ecosystem as it allows patients to gain a better understanding of their disease while also coordinating their care needs,” he added.
The Diabetes Care Administration Network is expected to launch by the end of 2019 and will first, be made accessible to over 25,000 patients through accountable care organisation Arizona Care Network.